HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Giuseppe Ippolito Selected Research

Interleukin 1 Receptor Antagonist Protein (Anakinra)

10/2021Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial.
10/2021Author Correction: Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial.
2/2021A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Giuseppe Ippolito Research Topics

Disease

55Infections
12/2021 - 03/2002
53COVID-19
11/2022 - 01/2020
20Tuberculosis (Tuberculoses)
01/2021 - 03/2003
16Communicable Diseases (Infectious Diseases)
12/2022 - 11/2005
9Neoplasms (Cancer)
01/2022 - 11/2002
8Viremia
01/2022 - 06/2005
7Latent Tuberculosis
10/2018 - 01/2007
5Respiratory Insufficiency (Respiratory Failure)
11/2021 - 10/2015
5Disease Progression
10/2021 - 09/2010
5Pneumonia (Pneumonitis)
07/2021 - 10/2010
5Human Influenza (Influenza)
06/2021 - 02/2010
4Inflammation (Inflammations)
12/2022 - 01/2020
4Malaria
08/2021 - 05/2009
4Chronic Hepatitis C
12/2019 - 04/2003
3B-Cell Lymphoma (Lymphoma, B Cell)
01/2022 - 07/2013
3Coinfection
08/2021 - 01/2005
3Necrosis
02/2021 - 01/2002
3Virus Diseases (Viral Diseases)
08/2020 - 05/2012
3Surgical Wound Infection
01/2020 - 04/2016
3Liver Diseases (Liver Disease)
07/2019 - 05/2006
3Ebola Hemorrhagic Fever
01/2019 - 01/2018
3Liver Cirrhosis (Hepatic Cirrhosis)
01/2018 - 04/2003
3Fibrosis (Cirrhosis)
01/2018 - 05/2014
3Sexually Transmitted Diseases (Sexually Transmitted Disease)
10/2013 - 09/2002
3HIV Infections (HIV Infection)
06/2011 - 03/2004
2Breast Neoplasms (Breast Cancer)
04/2024 - 12/2023
2Myocarditis (Carditis)
12/2022 - 12/2014
2Lymphopenia (Lymphocytopenia)
12/2021 - 11/2020
2Cardiovascular Diseases (Cardiovascular Disease)
12/2021 - 07/2021
2Monoclonal Gammopathy of Undetermined Significance
06/2021 - 01/2021
2Cross Infection (Nosocomial Infection)
01/2021 - 10/2010
2Dengue (Dengue Fever)
10/2020 - 01/2018
2Zika Virus Infection
09/2019 - 01/2017
2Heart Diseases (Heart Disease)
05/2019 - 12/2014
2Hepatitis
01/2019 - 10/2013
2Fever (Fevers)
01/2019 - 10/2009
2Persistent Infection
01/2019 - 03/2004
2Renal Insufficiency (Renal Failure)
02/2016 - 04/2013
2Lymphoma (Lymphomas)
11/2015 - 04/2011
2Hepatitis C
07/2014 - 05/2014
2Sepsis (Septicemia)
10/2010 - 03/2002

Drug/Important Bio-Agent (IBA)

18AntigensIBA
12/2021 - 09/2002
16VaccinesIBA
11/2022 - 12/2002
14Proteins (Proteins, Gene)FDA Link
11/2022 - 03/2003
14Biomarkers (Surrogate Marker)IBA
08/2022 - 01/2007
13Antiviral Agents (Antivirals)IBA
12/2021 - 05/2011
11RNA (Ribonucleic Acid)IBA
01/2022 - 09/2002
9InterferonsIBA
12/2021 - 09/2010
9CytokinesIBA
08/2021 - 09/2010
7Immunoglobulin G (IgG)IBA
12/2021 - 01/2019
7AntibodiesIBA
12/2021 - 09/2005
7Peptides (Polypeptides)IBA
06/2021 - 03/2003
6Viral RNAIBA
12/2021 - 05/2011
6Indicators and Reagents (Reagents)IBA
06/2021 - 01/2007
6Anti-Bacterial Agents (Antibiotics)IBA
04/2013 - 10/2008
5Messenger RNA (mRNA)IBA
01/2022 - 01/2017
5Immunoglobulin M (IgM)IBA
01/2022 - 01/2019
4Interleukin-6 (Interleukin 6)IBA
04/2021 - 10/2020
4Interferon-gamma (Interferon, gamma)IBA
02/2021 - 09/2002
4Monoclonal AntibodiesIBA
01/2021 - 07/2013
4GoldIBA
01/2018 - 01/2008
3remdesivirIBA
05/2022 - 10/2020
3mRNA VaccinesIBA
01/2022 - 01/2021
3Gonadal Steroid Hormones (Sex Hormones)IBA
11/2021 - 01/2021
3Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
10/2021 - 02/2021
3Interleukin-8 (Interleukin 8)IBA
04/2021 - 10/2020
3Interleukin-2 (IL2)IBA
02/2021 - 07/2010
2Angiotensin-Converting Enzyme 2IBA
12/2022 - 04/2021
2COVID-19 VaccinesIBA
01/2022 - 01/2021
2Lipoproteins (Lipoprotein)IBA
12/2021 - 05/2012
2Testosterone (Sustanon)FDA Link
11/2021 - 07/2021
2PlasminogenIBA
10/2021 - 10/2021
2Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
10/2021 - 10/2021
2Beclin-1IBA
10/2021 - 02/2016
2Neutralizing AntibodiesIBA
10/2021 - 01/2021
2Interleukin-13IBA
08/2021 - 02/2021
2SteroidsIBA
07/2021 - 12/2014
2BNT162 VaccineIBA
06/2021 - 01/2021
2InterleukinsIBA
02/2021 - 01/2002
2Chemokine CCL5IBA
02/2021 - 01/2021
2Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
02/2021 - 09/2010
2NucleoproteinsIBA
01/2021 - 02/2010
2Heparin (Liquaemin)FDA LinkGeneric
01/2021 - 08/2010
216S Ribosomal RNAIBA
01/2021 - 01/2021
2Tuberculin (PPD)IBA
03/2019 - 01/2008
2favipiravirIBA
01/2019 - 01/2017
2Rifampin (Rifampicin)FDA LinkGeneric
01/2018 - 04/2013
2CreatinineIBA
01/2018 - 04/2013
2EnzymesIBA
12/2016 - 04/2003
2Rituximab (Mabthera)FDA Link
07/2013 - 04/2011
2Interferon-alpha (Interferon Alfa)IBA
09/2010 - 12/2004

Therapy/Procedure

38Therapeutics
01/2022 - 12/2002
6Critical Care (Surgical Intensive Care)
12/2022 - 05/2009
6Highly Active Antiretroviral Therapy (HAART)
01/2012 - 08/2003
5Drug Therapy (Chemotherapy)
12/2023 - 07/2009
3Artificial Respiration (Mechanical Ventilation)
07/2021 - 10/2015
3Cesarean Section (Caesarean Section)
01/2020 - 04/2016
2Liver Transplantation
01/2022 - 03/2016
2Length of Stay
07/2021 - 07/2021
2Duration of Therapy
01/2018 - 10/2010